Volume 27, Number 4, 2011

Total Page:16

File Type:pdf, Size:1020Kb

Volume 27, Number 4, 2011 John J. Moulds mcmxliii–mmxi VOLUME 27, N UMBER 4, 2011 Immunohematology Volume 27, Number 4, 2011 CONTENTS I N M EMORI A M 117 John J. Moulds G.M. Meny Tribute to John J. Moulds 118 S. Nance, J. Vincent, M.K.G. Moulds, J.M. Moulds, T.S. Casina, and C. Flickinger R EVIEW 131 The ISBT 700 series of low-incidence and 901 series of high- incidence blood group antigens M.E. Reid R EVIEW 136 The LW blood group system: a review M.K.G. Moulds O RIGIN A L R EPORT 143 Occurrence of antibodies to low-incidence antigens among a cohort of multiply transfused patients with sickle cell disease P. Jack son O RIGIN A L R EPORT 146 Determination of optimal method for antibody identification in a reference laboratory J.R. Haywood, M.K.G. Moulds, and B.J. Bryant O RIGIN A L R EPORT 151 Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery S. Josefy, R. Briones, and B.J. Bryant C OMMUNIC ATION 154 Letter from the editors Thank you to the contributors to the 2011 issues 155 A NNOUNCEMENTS 158 A DVERTISEMENTS Index 162 Volume 27, Nos. 1, 2, 3, and 4, 2011 166 I NSTRUCTIONS FOR A UTHORS E DITOR - IN -C HIEF E DITORI A L B OA RD Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Joyce Poole, FIBMS Pomona, California Bristol, United Kingdom M A N AGING E DITOR Cynthia Flickinger, MT(ASCP)SBB James P. AuBuchon, MD Mark Popovsky, MD Philadelphia, Pennsylvania Seattle, Washington Braintree, Massachusetts Martha R. Combs, MT(ASCP)SBB Marion E. Reid, PhD, FIBMS S ENIOR M EDIC A L E DITOR Durham, North Carolina New York City, New York Geralyn M. Meny, MD Geoffrey Daniels, PhD S. Gerald Sandler, MD Philadelphia, Pennsylvania Bristol, United Kingdom Washington, District of Columbia TECHNIC A L E DITOR Anne F. Eder, MD Jill R. Storry, PhD Dawn M. Rumsey, ART (CSMLT) Washington, District of Columbia Lund, Sweden Glen Allen, Virginia George Garratty, PhD, FRCPath David F. Stroncek, MD Pomona, California Bethesda, Maryland A SSOCI ATE M EDIC A L E DITORS Brenda J. Grossman, MD David Moolten, MD St. Louis, Missouri E MERITUS E DITOR Philadelphia, Pennsylvania Christine Lomas-Francis, MSc Delores Mallory, MT(ASCP) SBB Ralph R. Vassallo, MD New York City, New York Supply, North Carolina Philadelphia, Pennsylvania Paul M. Ness, MD E DITORI A L A SSISTA NT Baltimore, Maryland Sheetal Patel C OPY E DITOR Mary L. Tod P ROOFRE A DER Lucy Oppenheim Immunohematology is published quarterly (March, June, September, and December) by the American Red Cross, National Headquarters, Washington, DC 20006. P RODUCTION A SSISTA NT Immunohematology is indexed and included in Index Medicus and MEDLINE on the Marge Manigly MEDLARS system. The contents are also cited in the EBASE/Excerpta Medica and Elsevier BIOBASE/Current Awareness in Biological Sciences (CABS) databases. E LECTRONIC P UBLISHER The subscription price is $40.00 (U.S.) and $50.00 (foreign) per year. Paul Duquette Subscriptions, Change of Address, and Extra Copies: Immunohematology, P.O. Box 40325 Philadelphia, PA 19106 Or call (215) 451-4902 Web site: www.redcross.org/immunohematology Copyright 2011 by The American National Red Cross ISSN 0894-203X O N O UR C OVER Never forget the history . John J. Moulds July 29, 1943–June 13, 2011 I N M E M OR I A M John J. Moulds G.M. Meny John J. Moulds, the widely acclaimed leader in transfusion medicine, died on June 13, 2011, after battling pancreatic cancer. He was 67. John was a 1961 graduate of Rapid City High School in Rapid City, South Dakota, and a 1965 graduate of Chadron State. He became a certified medical technologist after completing studies at St. John’s McNamara Hospital in Rapid City, South Dakota, and earned the specialist in blood banking from the American Society for Clinical Pathology after completing studies at the Minneapolis War Memorial Blood Bank. John was a longtime participant in the field of transfusion medicine. He published approximately 100 scientific papers, presented lectures on every continent except Antarctica, and was named to several technical advisory boards. He founded and directed the Serum, Cells, and Rare Fluids Exchange, whose membership has expanded to more than 150 immunohematologists. John received numerous awards in recognition of his achievements, including the 1983 AABB Ivor Dunsford Award, the 2003 AABB/National Blood Foundation Sally Frank Award/Lectureship, the 2007 University of Texas Medical Branch L. Jean Stubbins Memorial Lectureship, and the 2011 International Society for Blood Transfusion Presidential Award. Recently, the LifeShare Reference and Scientific Support Laboratories at Shreveport, Louisiana, were named for John. We are honored that John served on the editorial board of Immunohematology for 15 years, beginning in 1997. His knowledge and valuable insight will be missed. Survivors include his wife, Dr. Joann Moulds, and two daughters, Dr. Terri Moulds Bowen and Dr. Christie Moulds-Merritt. Geralyn M. Meny, MD, MS Senior Medical Editor, Immunohematology The following tributes to John Moulds include testimonials from colleagues as well as reiterations of presentations from the dedication of the LifeShare Reference and Scientific Support Laboratories in February 2011. IMMUNOHEMATOLOGY, Volume 27, Number 4, 2011 117 Tribute to John J. Moulds S. Nance, J. Vincent, M.K.G. Moulds, J.M. Moulds, T.S. Casina, and C. Flickinger John J. Moulds, MT(ASCP)SBB John J. Moulds had a prolific career in immunohematology. For the 2011 South Central Association of Blood Banks (SCABB) His name is synonymous with analytic scientist. From my annual meeting, I nominated John Moulds for the Larry L. Trow Memorial Education Award. This award is for people who have perspective, John’s most admirable trait and one that we shown excellence in education in blood banking. The following is should all strive for was his genuine and incisive interest in a reiteration of my nomination of John for the award, which, by the case, whether presented by an esteemed colleague or a the way, he won. student. He endeavored to find the reason for the results and what it meant for the patient’s care. He was a truth seeker, John Moulds spent his career providing education to eagerly remembering the past to help solve today’s case! One the blood bank community in many different aspects. I first of my favorite recollections is talking at length (was there any met John while I was an SBB student when he was working other way with John?) about a very minute detail of a most at Gamma Biologicals in Houston, Texas. I do believe my complex case from the past, which of course was always the knowledge of the Lewis system and my philosophy of antibody clue that led to the resolution. He was always the one with the identification came from that short week with John. I will corporate memory; it was John who could tell us the family never forget him saying, “Don’t look for unicorns until you members by name and type, which laboratory studied the have ruled out the zebras.” case, the exact reactivity of the samples in each of the media, Besides his work with Gamma, he worked for Ortho as and the conclusion for the case. a Senior Research Fellow and more recently as the Director Immunohematology benefitted immeasurably from his of Scientific Support Services at LifeShare Blood Center. No experience and ideas, and we miss his presence. John served on matter what his job was, he always found time to teach at local, the editorial board of Immunohematology for many years, and national, and international meetings. In 1972, he founded and I and the rest of the editorial board members are truly grateful was director of the Serum, Cells, and Rare Fluid (SCARF) for his contributions and opinions. In one of his last attendances International Exchange. John has chaired committees for at the annual editorial board meetings, John offered to do the AABB and SCABB; he was a peer reviewer for Vox Sanguinis centerfold. Let me explain. Immunohematology has a new and Transfusion, and served on the editorial board for feature that will be used, when appropriate, to help educate our Immunohematology. staff and students. This is a page within the journal containing John’s association with my SBB program prompted me serologic, technical, or blood group information that can to nominate him for the Larry L. Trow Memorial Education be separated and posted for educational purposes, in other Award for Education. He spent one day with my SBB students words, a centerfold. Alas, John did not get to complete this. telling them how to become the best blood bankers ever, and But the first centerfold, with his beloved “orphan” antigens of he did this on his own time and with his own money! When the 700 series, appears in this issue. The tributes in this issue answering students’ questions, he would ask beforehand, “Do give credence to the intensity of his aura in the transfusion you want the long or the short version?” I do think his goal medicine science community. was to instill his love of antibodies in the future blood bankers. He had my students on the edge of their seats waiting for the Sandra Nance, MS, MT(ASCP)SBB next story, the next tidbit of information. He was a role model Editor-in-Chief, Immunohematology for teachers and for anyone who wanted to make antibody American Red Cross Biomedical Services identification their life’s work. He would pick up the phone Penn-Jersey Region and talk to somebody who was emailing about a problem.
Recommended publications
  • Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS
    Journal of Blood Group Serology and Molecular Genetics VOLUME 34, N UMBER 1, 2018 This issue of Immunohematology is supported by a contribution from Grifols Diagnostics Solutions, Inc. Dedicated to advancement and education in molecular and serologic immunohematology Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS S EROLOGIC M ETHOD R EVIEW 1 Warm autoadsorption using ZZAP F.M. Tsimba-Chitsva, A. Caballero, and B. Svatora R EVIEW 4 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A brief overview of clinical significance of blood group antibodies M.J. Gandhi, D.M. Strong, B.I. Whitaker, and E. Petrisli C A S E R EPORT 7 Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation R. Shree, K.K. Ma, L.S. Er and M. Delaney R EVIEW 11 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies S.J. Nance S EROLOGIC M ETHOD R EVIEW 16 Recovery of autologous sickle cells by hypotonic wash E. Wilson, K. Kezeor, and M. Crosby TO THE E DITOR 19 The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor L.L.W.
    [Show full text]
  • Introduction to the Rh Blood Group.Pdf
    Introduction to the Rhesus Blood Group Justin R. Rhees, M.S., MLS(ASCP)CM, SBBCM University of Utah Department of Pathology Medical Laboratory Science Program Objectives 1. Describe the major Rhesus (Rh) blood group antigens in terms of biochemical structure and inheritance. 2. Describe the characteristics of Rh antibodies. 3. Translate the five major Rh antigens, genotypes, and haplotypes from Fisher-Race to Wiener nomenclature. 4. State the purpose of Fisher-Race, Wiener, Rosenfield, and ISBT nomenclatures. Background . How did this blood group get its name? . 1937 Mrs. Seno; Bellevue hospital . Unknown antibody, unrelated to ABO . Philip Levine tested her serum against 54 ABO-compatible blood samples: only 13 were compatible. Rhesus (Rh) blood group 1930s several cases of Hemolytic of the Fetus and Newborn (HDFN) published. Hemolytic transfusion reactions (HTR) were observed in ABO- compatible transfusions. In search of more blood groups, Landsteiner and Wiener immunized rabbits with the Rhesus macaque blood of the Rhesus monkeys. Rhesus (Rh) blood group 1940 Landsteiner and Wiener reported an antibody that reacted with about 85% of human red cell samples. It was supposed that anti-Rh was the specificity causing the “intragroup” incompatibilities observed. 1941 Levine found in over 90% of erythroblastosis fetalis cases, the mother was Rh-negative and the father was Rh-positive. Rhesus macaque Rhesus (Rh) blood group Human anti-Rh and animal anti- Rh are not the same. However, “Rh” was embedded into blood group antigen terminology. The
    [Show full text]
  • Safe Blood and Blood Products
    Safe Blood and Blood Products Module 3 Blood Group Serology Safe Blood and Blood Products Module 3 Blood Group Serology Conversion of electronic files for the website edition was supported by Cooperative Agreement Number PS001426 from the Centers for Disease Control and Prevention (CDC), Atlanta, United States of America. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. © World Health Organization, reprinted 2009 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Blood Group Compatibility
    BLOOD GROUP COMPATIBILITY Blood grouping identifies the ABO and Rh type of a recipient or donor. This grouping ensures that the patient receives compatible blood products. The ABO Blood Group System The ABO blood group is determined by the A or B antigen attached to the membrane of the red blood cell. Group A persons inherit the A antigen and make anti-B antibodies which destroy cells carrying B antigens. Group B persons inherit the B antigen and make anti-A antibodies which destroy cells carrying A antigens. Group AB persons inherit the A and B antigen and do not make either A or B “antibodies”. Group O persons do not inherit the A or B antigen and make “antibodies” which destroy cells carrying A or B antigens. Antibodies against A and B antigens are produced spontaneously in the plasma within the first few months of life. Blood Group Antigen on Red Cell Antibodies in Plasma A A antigen Anti-B B B antigen Anti-A AB both A & B antigens neither Anti-A or Anti-B O neither A & B antigens Anti-A and Anti-B Rhesus (Rh) Blood Group System The Rh type is determined by the presence or absence of the Rh “D” antigen on the red cells. • Rh positive – D antigen is present • Rh negative – D antigen is absent Unlike the ABO system, there are no naturally occurring Rh antibodies. Anti-D is produced when an Rh negative individual is exposed to Rh positive red cells (e.g. through transfusion or pregnancy). Rh antigens are carried on red cells only.
    [Show full text]
  • Prevalence of ABO, Rhd and Other Clinically Significant Blood Group Antigens Among Blood Donors at Tertiary Care Center, Gwalior
    ORIGINAL ARTICLE Bali Medical Journal (Bali Med J) 2020, Volume 9, Number 2: 437-443 P-ISSN.2089-1180, E-ISSN.2302-2914 Prevalence of ABO, RhD and other clinically ORIGINAL ARTICLE significant Blood Group Antigens among blood donors at tertiary care center, Gwalior Published by DiscoverSys CrossMark Doi: http://dx.doi.org/10.15562/bmj.v9i2.1779 Shelendra Sharma, Dharmesh Chandra Sharma,* Sunita Rai, Anita Arya, Reena Jain, Dilpreet Kaur, Bharat Jain Volume No.: 9 ABSTRACT Issue: 2 Background: Among all blood group systems and antigens, ABO and of them 1000 randomly selected donor samples were processed for D antigens of the Rh blood group system are of primary importance, complete Rh, Kell, Duffy and Kidd blood grouping. hence included in routine blood grouping and transfusion. Other blood Result: ABO group pattern was; A - 22.56%, B - 36.52%, AB - 9.8% group systems and antigens that are important in multiparous women, and O -31.12 %, while RhD status was RhD+ 90.99% and RhD- 9.01%. First page No.: 437 multi-transfused patients and hemolytic disease of newborn are Kell, Prevalence of Rh phenotypes was DCCee 43%, DCcee 33%, DCcEe 10%, Rh, Duffy, and Kidd. dccee 6.5%, DccEe 4.5%, Dccee 1%, DCCEe 0.3% and dccEe 0.2%. Aims and Objectives: To know the pattern of ABO, RhD and other Kell phenotype was K-k+ 95.5%, K+k+ 4.5%, while K+ k- and K- clinically significant major antigens of Rh, Kell, Duffy and Kidd blood k- phenotypes were not encountered in this study. Duffy phenotypes P-ISSN.2089-1180 group systems as well as evaluation of phenotypes, genotypes and were Fya+ Fyb+ 47.5%, Fya+ Fyb- 35%, Fya- Fyb+17% and Fya- Fyb- gene frequency of related antigens among blood donors in Gwalior 0.5%.
    [Show full text]
  • Blood Grouping
    WHO GMP ANTISERA CERTIFIED ANTISERA J. MITRA Ensure Your Blood Compatibility with our Product Range... & CO. PVT. LTD. The ABO blood group system is a classification system for the antigens of human blood discovered by Karl Landsteiner in 1900. There are four blood groups : A, B, AB and O. The Rh blood group system is the second most significant system for blood grouping. Rh factor refer to Rh D antigen only. Determination of Rh factor along with ABO is essential for defining the Rh +ve or Rh -ve status of the individual. Around 85% of the human population is Rh +ve while 15% is Rh -ve. The ABO & Rh systems are the most significant blood group systems from the clinical point of view. JML Range of Blood Grouping... Anti-A Monoclonal Anti-B Monoclonal Anti-AB Monoclonal Anti-D (IgM) Rh1 Monoclonal Anti-D (IgG+IgM) Rh1 Monoclonal Anti-H Lectin Anti-A1 Lectin Anti Human Serum Bovine Albumin AANNTTII--HH LLEECCTTIINN AABBOO BBLLOOOODD GGRROOUUPPIINNGG Ulex europaeus lectin for slide and Tube Tests (Anti-A, Anti-B, Anti-AB, Anti-D (IgM) & Anti-D (IgG + IgM) Monoclonal) Anti-H Lectin is used to show the presence of Salient Features: The routine practice of blood typing and cross-matching blood products prevent adverse 'H' antigen on human red blood cells. The 'H' Excellent Avidity antigen is a precursor of A & B antigen. transfusion reactions caused by ABO antibodies. ABO blood grouping is used to check Clearly visible agglutination the RBCs & plasma compatibility of donor and recipient before blood transfusion. Individuals that test as type 'O' by ABO blood Shelf Life : 24 months at 2-8ºC group system may have Bombay Phenotype (hh).
    [Show full text]
  • Safe Blood and Blood Products
    Safe Blood and Blood Products Module 3 Blood Group Serology Safe Blood and Blood Products Module 3 Blood Group Serology Conversion of electronic files for the website edition was supported by Cooperative Agreement Number PS001426 from the Centers for Disease Control and Prevention (CDC), Atlanta, United States of America. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. © World Health Organization, reprinted 2009 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Essentials of Blood Group Antigens and Antibodies
    Essentials of Blood Group Antigens and Antibodies Non-Medical Authorisation of blood Components Nov 2017 East Midlands Regional Transfusion Committee Transfusion Terminology Antigens and Antibodies Antibodies Antigens Blood Group Antigens • Antigens are part of the surface of cells – Red Cells have “Blood group antigens” – White cells and platelets have HLA antigens (platelets also have HPA antigens) https://www.ncbi.nlm.nih.gov/books/NBK2264/bin/imagemap.jpg Reactions to blood usually occurs when the antigen on the donor cells reacts with an antibody in the patient’s plasma What Are Blood Group Antigens? • Complex structures that contain protein and carbohydrate • Part of the membrane structure – blood group antigens often have a role e.g. structural, transport • Produced by inheritance of specific genes – genes produce different antigen options within one blood group system http://en.wikibooks.org/wiki/Structural_Biochemistry/Lipids/Lipid_Bilayer Blood Group Antigens • Currently 36 known blood group systems • Most clinically important are ABO and Rh • Antigens on donor red cells can stimulate a patient to produce an antibody, if the patient lacks the antigen themselves • Likelihood of antibody production is low but increases the more transfusions that are given What are Blood Group Antibodies? • Protein molecules - called https://en.wikipedia.org/wiki/Antibody#/medi a/File:Antibody.svg immunoglobulins (Ig) • Found in the plasma/serum – Produced by the immune system following exposure to a foreign antigen – Antibodies bind specifically
    [Show full text]
  • A Study to Find out Association Between Blood Group and Platelet Count
    National Journal of Physiology, Pharmacy and Pharmacology RESEARCH ARTICLE A study to find out association between blood group and platelet count Nileshwari H Vala, Gitesh J Dubal Department of Physiology, Shri M. P. Shah Government Medical College, Jamnagar, Gujarat, India Correspondence to: Gitesh J Dubal, E-mail: [email protected] Received: October 28, 2018; Accepted: November 18, 2018 ABSTRACT Background: Blood group antigens are protein structure on red blood cell membrane, and platelet has receptors on its surface for binding which are also protein in nature. Aims and Objectives: Thus, some genetic association for certain blood group types with platelet function and count can shade some light in this area of research. Materials and Methods: A total of 51 cases were included in the present study. All healthy male and female subjects above 18 years were included in our study. Prior Indian Ethics Committee approval was taken, and information sheet was provided about the present study and only when voluntary consent subjects’ 0.5 ml venous blood was collected aseptically. Basic information about name, age, and gender was collected. Platelet count was calculated using an autoanalyzer instrument. Data analysis was done using MedCalc v18.6 software. P < 0.05 was considered significant. Results: Out of 51 cases the majority of subjects were A positive and B positive with 16 in each case. Highest platelet count was found in B positive blood group at 241562 ± 69970. Lowest platelet count was found in AB positive blood group at 216142 ± 51689. Conclusion: On applying single factor ANOVA for finding out the association between platelet count and blood group, P value was present at 0.934.
    [Show full text]
  • Blood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-Ctl-Neutral-Neutral
    Blood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-ctl-Neutral-Neutral English, B186350, Version 05, 2016.07 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S. License Number: 1845 Product-Identification: 71000 IH-Card ABO/D(DVI-)+Rev A1, B: VOL12 cards per box REF 813 110 100 VOL 48 cards per box REF 813 111 100 VOL 288 cards per box REF 813 112 100 INTENDED USE The IH-Card ABO/D(DVI-)+Rev A1, B is intended for the performance of forward and reverse ABO grouping and D (RH1) antigen typing of human red blood samples using the IH-System. SUMMARY Between 1900 and 1902, Karl Landsteiner and associates discovered the ABO system of red blood cell antigens. The importance of this discovery is the recognition that antibodies are present when the corresponding antigens are lacking. The ABO system is the only blood group system in which the reciprocal antibodies are consistently and predictably present in most people. Due to this reciprocity, a blood type determination is considered valid if serum grouping corresponds with red blood cell grouping.1 ABO blood group typing, using Anti-A and Anti-B antisera to detect the A (ABO1) and B (ABO2) antigens, is known as direct or forward grouping. Reverse grouping (serum grouping test) uses Reagent Red Blood Cells of known ABO antigen specificity to indicate the presence or absence of anti-A and anti-B antibodies. Discrepancies between forward and reverse grouping require further investigation.
    [Show full text]
  • Immunohematology Vol 21, #4
    D DDD D DDD D D D DDD D DDD D D ImmunohematologyD D D D JOURNALDD OF BLOOD GROUP SEROLOGYDD AND EDUCATION D D DDD D DDD D DDD D DDD D D D DDD D DDD D DDD D DDD D D D DDD D DDD D DDD D DDD D D D DDV OLUMED 21, NUMBER 4,D 2005 D D D Immunohematology JOURNAL OF BLOOD GROUP SEROLOGY AND EDUCATION VOLUME 21, NUMBER 4, 2005 CONTENTS 141 Review: the Rh blood group system: an historical calendar P. D . I SSITT 146 Reactivity of FDA-approved anti-D reagents with partial D red blood cells W. J. J UDD,M.MOULDS,AND G. SCHLANSER 149 Case report: immune anti-D stimulated by transfusion of fresh frozen plasma M. CONNOLLY,W.N.ERBER,AND D.E. GREY 152 Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200 C.M. JENKINS, S.T. JOHNSON, D.B. BELLISSIMO,AND J.L. GOTTSCHALL 155 Review: the Rh blood group D antigen . dominant, diverse, and difficult C.M.WESTHOFF 164 COMMUNICATIONS Letters from the editors Ortho-Clinical Diagnostics sponsorship Thank you to contributors to the 2005 issues 166 168 Letters from the outgoing editor-in-chief Letter from the incoming editorial staff Thank you with special thanks to Delores Changing of the guard 169 IN MEMORIAM John Maxwell Bowman, MD; Professor Sir John V.Davies, MD;Tibor J.Greenwalt, MD; and Professor J.J.Van Loghem 174 176 177 ANNOUNCEMENTS UPCOMING MEETINGS ADVERTISEMENTS 180 INSTRUCTIONS FOR AUTHORS 181 INDEX — V OLUME 21, NOS.
    [Show full text]
  • ABO and Rh Blood Grouping & Typing
    ABO and Rh Blood Grouping & Typing Teaching Aim • Understanding inheritance, synthesis, various antigens and antibodies and their clinical significance in ABO & Rh blood group systems • Understanding practical aspects of ABO & Rh blood grouping Human Blood Groups • Red cell membranes have antigens (protein / glycoprotein) on their external surfaces • These antigens are o unique to the individual o recognized as foreign if transfused into another individual o promote agglutination of red cells if combine with antibody o more than 30 such antigen systems discovered • Presence or absence of these antigens is used to classify blood groups • Major blood groups – ABO & Rh • Minor blood groups – Kell, Kidd, Duffy etc ABO Blood Groups • Most well known & clinically important blood group system. • Discovered by Karl Landsteiner in 1900 • It was the first to be identified and is the most significant for transfusion practice • It is the ONLY system that the reciprocal antibodies are consistently and predictably present in the sera of people who have had no exposure to human red cells • ABO blood group consist of o two antigens (A & B) on the surface of the RBCs o two antibodies in the plasma (anti-A & anti-B) Reciprocal relationship between ABO antigens and antibodies Antigens on Antibody in plasma / Blood group RBCs serum A Anti-B A B Anti-A B AB None AB None Anti-A, Anti-B O Development at birth . All the ABH antigens develop as early as day 37 of fetal life but do not increase very much in strength during gestational period . Red cell of newborn carry 25-50 % of number of antigenic sites found on adult RBC .
    [Show full text]